@article{ref1,
title="Suicidality and COVID-19: suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review)",
journal="Experimental and therapeutic medicine",
year="2022",
author="Efstathiou, Vasiliki and Stefanou, Maria-Ioanna and Siafakas, Nikolaos and Makris, Michael and Tsivgoulis, Georgios and Zoumpourlis, Vassilios and Spandidos, Demetrios A. and Smyrnis, Nikolaos and Rizos, Emmanouil N.",
volume="23",
number="1",
pages="e107-e107",
abstract="Since the outbreak of the coronavirus 2019 (COVID-19) pandemic, there has been widespread concern that social isolation, financial stress, depression, limited or variable access to health care services and other pandemic-related stressors may contribute to an increase in suicidal behaviors. In patients who have recovered from COVID-19, an increased risk of developing suicidal behaviors may be noted, while post-COVID syndrome comprises another potential risk factor contributing to increased suicidal behaviors. Despite the initial alarming predictions for an increase in suicide rates due to the COVID-19 pandemic, the majority of published studies to date suggest that experienced difficulties and distress do not inevitably translate into an increased number of suicide-related deaths, at least not in the short-term. Nevertheless, the long-term mental health effects of the COVID-19 pandemic have yet to be unfolded and are likely to remain for a long period of time. Suicide prevention and measures aiming at promoting well-being and mitigating the effects of COVID-19 on mental health, particularly among vulnerable groups, should thus be a priority for healthcare professionals and policymakers amidst the evolving COVID-19 pandemic.<p /> <p>Language: en</p>",
language="en",
issn="1792-0981",
doi="10.3892/etm.2021.11030",
url="http://dx.doi.org/10.3892/etm.2021.11030"
}